This inventor holds 1 USPTO granted patent. Top assignee: Infosys Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Saurabh Bundela: Innovator in Drug Repurposing
Introduction
Saurabh Bundela is a notable inventor based in Chhatarpur, India. He has made significant contributions to the field of drug repurposing, showcasing his innovative spirit and dedication to improving healthcare solutions. His work focuses on developing methods that can enhance the efficacy of existing drugs for new therapeutic indications.
Latest Patents
Saurabh Bundela holds a patent titled "Methods for drug repurposing and devices thereof." This invention provides a comprehensive method and system for drug repurposing. The disclosed embodiment includes selecting a set of positive drugs for a specific indication and listing pathways associated with both positive and negative drugs. The method involves calculating a pathway weight based on the action of each drug, ultimately identifying a drug score for repurposing. This innovative approach allows for the repurposing of drugs with relatively high scores for new indications, potentially transforming treatment options.
Career Highlights
Saurabh Bundela is currently employed at Infosys Limited, where he continues to work on innovative projects that leverage technology to improve healthcare outcomes. His expertise in drug repurposing positions him as a valuable asset in the field of pharmaceutical research and development.
Collaborations
Saurabh collaborates with talented individuals such as Krutin Kumar Boloor and Pooja Durgad. Their combined efforts contribute to advancing research and innovation in drug repurposing.
Conclusion
Saurabh Bundela's work in drug repurposing exemplifies the impact of innovation in healthcare. His patent and ongoing contributions at Infosys Limited highlight his commitment to improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
